Menu

Shares Magazine

Magazine
- Back
- Latest Issue: 25 Sep 2025
- Archives
  
  18 Sep 2025
  
  11 Sep 2025
  
  04 Sep 2025
  
  28 Aug 2025
  View all
- More Reading
Tools
- Back
- Market Data
  - Back
  - Share Prices
  - Indices
  - Funds
  - Forex
  - IPOs
  - Market Diary
- Market Tools
  - Back
  - Portfolio
  - Stockwatch
  - Market Scan
  - Charts
  - Alerts
- Director Deals
  - Back
  - Director Deals
  - Latest Deals
  - Analysis
  - Search
  - Alerts
News
- Back
- Shares News
  Shares journalists news and views on today's breaking stories.
- Market & Company News
  A comprehensive daily news service of over 300 market and company stories from Alliance News and the RNS.
Awards
- Back
- Investment Awards
  
  The AJ Bell Investment Awards is your chance to vote for your pick of active and passive funds.
Events
Videos
Podcasts
Contact us and help Subscribe

Search results for 'novo nordisk'

Shares Comment Stock Quotes Videos Events

Filter

Loading filters...

Showing 49 to 64 of 163 |

Filter

World’s biggest sovereign wealth investor is a fan of UK equities

If we took a straw poll of readers and asked which country has the world's biggest sovereign wealth fund, the chances are Saudi Arabia and Singapore would come high up the list if not at the top.In fact, the largest is Norway's...

16 May 2024
FTSE 100 hits record high as UK leaves recession

London stocks were up at midday on Friday, on the back of an interest rate hold from the Bank of England and a better-than-expected gross domestic product reading from the Office for National Statistics.The FTSE 100 index was up...

10 May 2024
Why competition in the market for obesity drugs just got tougher

The emerging battle for market share in the lucrative obesity market, which analysts at Goldman Sachs estimate could be worth more than $100 billion by 2030, is starting to heat up.Sales of market-leading weight-loss drug Wegovy...

09 May 2024
Wegovy obesity drug maker Novo Nordisk increases full year outlook

Sales and profit ahead of expectationsFull year outlook raisedWegovy demand outstripping supplyDanish pharmaceutical giant Novo Nordisk (NOVO-B:CPH), known for its leading weight-loss drug Wegovy, delivered better than expected...

02 May 2024
Take advantage of Scottish American’s discount to NAV to pick up quality companies on the cheap

Scottish American Investment Company (SAIN) 503pMarket cap: £898 millionBallie Gifford-managed Scottish American (SAIN), also referred to as ?SAINTS?, is trading at an 8% discount to net asset value which offers a great...

02 May 2024
How Fundsmith stacks up versus Nutshell and Blue Whale rivals

If you had £10,000 to invest in a single fund, which would you choose ? one of the most popular with retail investors for more than a decade, or a relative new kid on the block with a similar asset allocation approach?In a manner...

18 April 2024
AstraZeneca hikes dividend as shareholders vote on CEO’s pay

Annual dividend upped 7% to $3.10Shareholders vote on CEO pay increaseSoriot one of the highest paid FTSE 100 CEOsPharmaceutical giant AstraZeneca (AZN) announced a 7% increase in the annualised dividend to $3.10 per share which...

11 April 2024
Invest in the future of medicine

At the centre of the current boom in generative AI (artificial intelligence) is chip maker Nvidia (NVDA:NASDAQ).It designs some of the fastest computer chips in the world which are needed to run data hungry LLMs (large language...

04 April 2024
How catchy names like the Magnificent Seven hook in investors

In a world of thousands of stocks, certain people just want to focus on ones that are doing well. If these stocks are part of a group with a snappy acronym or label, they must surely matter, right? That is the widespread view among...

28 March 2024
How all-weather global equity fund Brunner has rewarded our faith

Brunner Investment Trust (BUT) £12.75Gain to date: 19%We highlighted investment trust Brunner (BUT) at £10.71 in April 2023 on the basis a 7.1% discount to (NAV) net asset value provided an opportunity to purchase a balanced...

07 March 2024
Renalytix shares surge 50% on unsolicited takeover approach

Shares soar almost 50% on unsolicited approachBoard hoists ?for sale? sign amid strategic reviewDiscussions to raise new equity and debtAn unsolicited takeover approach for kidney diagnostics specialist Renalytix (RENX:AIM) sent...

04 March 2024
Broad-based rally takes S&P 500 and Nasdaq to new all-time highs | Wall Street Week

Despite all the doubts about the durability of the rally, US stocks continue to power head with the S&P 500 and Nasdaq Composite posting new life-highs during the past week leaving them up 7.5% and 9% respectively year-to-date.Both...

01 March 2024
Find out what Terry Smith thinks about obesity drugs and AI

Fundsmith founder Terry Smith and head of investment research Julian Robins were in good spirits while chatting with AJ Bell?s editor in chief Dan Coatsworth in a video interview.As usual, Smith was candid and open to discussing...

29 February 2024
Champions of Europe: how to invest in the continent’s best stocks

For years now, European equities have struggled to keep pace with their US counterparts, but the historically low valuations on the ?old continent? mean we could be at an inflection point with investors beginning to take notice at...

29 February 2024
When will markets appreciate European equities' lower valuations?

THIS IS AN ADVERTISING FEATUREAuthorBen RitchieInvestment Manager, Dunedin Income Growth Investment TrustEuropean equities have struggled to keep pace with their US counterparts for a few years. However, historically low European...

09 February 2024
Eli Lilly makes new high on strong Q4 and strong debut for obesity drug

Shares makes new high on strong Q4Debut of obesity drug Zepbound2024 to be slightly ahead of analysts' forecastsShares in healthcare giant Eli Lilly (LLY:NYSE) scaled fresh heights in US trading after the diabetes and weight loss...

07 February 2024

< Previous

2 3 4 5 6 7

Next >

Showing 49 to 64 of 163

Most Read

1
Gold takes out inflation-adjusted high as central banks look set to keep buying
2
Buy Rightmove for its resilient earnings growth
3
Three investment lessons from observing Warren Buffett over four decades
4
It’s goodbye for now in our final weekly issue
5
Our top share picks: Great ideas for the long term
6
Category killer Costco needs to deliver the goods next week
7
Our fund selection
8
Why it could be a great time to invest in RIT Capital Partners
9
Why Kingfisher shares are under the hammer
10
The IPO market is showing signs of life in both the UK and US

Shares Magazine Latest Issue Cover

Latest Issue:
25 Sep 2025

Market Overview

UK 350 Risers and Fallers

Terms And Conditions Investment Warning Privacy Disclaimers Cookies About Shares The Shares Team Contact Us

X Cookie Policy

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies from this website. You may change your preferences at any time.

Submitting...